Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
The in vitro and in vivo bioactivities of silibinin (SB), paclitaxel (PTX) and SB and PTX in combination (SB+PTX) against murine metastatic mammary 4T1 cancer cell line were investigated. Isobologram and combination index (CI) analyses showed that SB and PTX can function synergistically in the inhib...
Main Authors: | Bing-Ying Ho, Chun-Hung Lin, Maria Karmella Apaya, Wen-Wan Chao, Lie-Fen Shyur |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-10-01
|
Series: | Journal of Traditional and Complementary Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S222541101630116X |
Similar Items
-
The Toxic Effect of Silibinin and Paclitaxel Combination on Endometrial Cancer Cell Line
by: Ameneh Basiri, et al.
Published: (2016-10-01) -
Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer
by: Maria Karmella Apaya, et al.
Published: (2020-01-01) -
Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
by: Xiaoying Hou, et al.
Published: (2018-02-01) -
A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer
by: Chuanrong Chen, et al.
Published: (2021-02-01) -
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer
by: Maria Karmella Apaya, et al.
Published: (2019-05-01)